bioRxivMicrobiologyPreprint
Influence of perinatal ampicillin exposure on maternal fecal microbial and metabolic profiles
Simone ZuffaiD, Sydney P. ThomasiD, Ipsita MohantyiD, Yasin El AbieadiD, Victoria DelerayiD, Kine Eide KvitneiD, Armin KoushaiD, Emi Suzuki, Chih‐Ming TsaiiD, Griffith Nguyen, Benjamin Ho, George Y. LiuiD, Victor NizetiD, Pieter C. DorresteiniD, Fatemeh AskarianiD, Shirley M. TsunodaiD
Abstract
Indirect exposure to antibiotics during early life, via maternal intrapartum antibiotic prophylaxis (IAP) or postpartum maternal antibiotic usage, is increasingly common and has been epidemiologically linked to altered growth and immune developmental trajectories in offspring. Nevertheless, the underlying mechanisms remain poorly understood. Here, we explored the effects of antepartum and postpartum maternal ampicillin administration on the dams fecal microbiome and metabolic profiles in vivo. Ampicillin caused a reproducible depletion of beneficial bacterial species belonging to the Muribaculaceae family, including Muribaculum intestinale and Duncaniella dubosii, and led to cohort-dependent enrichments of Enterococcus and Prevotella species. These microbial alterations were accompanied by substantial metabolic remodeling, characterized by elevated fecal acylcarnitines and dysregulation of the bile acids profile. Intriguingly, we identified two previously uncharacterized trihydroxylated bile acids conjugated to a hexose moiety, which appeared to be associated with antibiotic exposure across public metabolomics repositories. These alterations in the fecal maternal microbiome and metabolome coincided with increased weight gain in offspring, suggesting a possible role for maternal antibiotic exposure in shaping early developmental trajectories. Further studies are warranted to elucidate the long-term implications of these changes in infant health. IMPORTANCEPerinatal antibiotic administration is a critical intervention to reduce maternal and neonatal infections, including early-onset group B Streptococcus (GBS) disease, a major cause of neonatal mortality. Nevertheless, mounting evidence suggests that the use of broad-spectrum antibiotics during the perinatal period in mothers can affect infant gut microbiome development, with potential consequences for immune maturation and early development. Understanding how maternal antibiotic exposure affects the gut microbiome and metabolome is essential for uncovering the potential pathways by which maternal intervention may influence offspring outcomes and for guiding strategies that balance infection control with long-term infant health.
- organism: mouse
- assay: metagenomics
- assay: metabolomics
- research focus: cell type annotation
- research focus: differential expression
- approach: statistical model
- Citations
- 3
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Perinatal ampicillin administration modulates murine bile acid metabolism in vivo - an observational study
S. P. Thomas, F. Askarian, … S. Tsunoda·bioRxiv·Jan 31, 2024
- Effect of Perinatal Ampicillin or Amoxicillin/Clavulanate Exposure on Maternal and Infant Gut Microbiome, Metabolome, and Infant Responses to the 20-valent Pneumococcal Conjugate Vaccine
Emi Suzuki, Victoria Deleray, … Fatemeh Askarian·Gut Microbes ReportsPeer-reviewed·Jul 20, 2026
- Antibiotic Exposure Through Human Milk Influences the Infant Gut Microbiome
Kine Eide Kvitne, Simone Zuffa, … Shirley M. Tsunoda·bioRxiv·Apr 1, 2026
- Antibiotics effects on the fecal metabolome in preterm infants
- Impact of gestational antibiotics on maternal and offspring gut microbiota and growth in pigs
Md. Rayhan Mahmud, Toomas Orro, … Mikael Niku·bioRxiv·Nov 8, 2025
- Early-life antibiotic exposure leads to gut microbial dysbiosis associated with neurodevelopment and neuroregeneration
Pianpian Fan, Xiang Zhou, … Qing Zhao·Experimental NeurologyPeer-reviewed·Jul 10, 2026